425 related articles for article (PubMed ID: 21278728)
21. Involvement of the endocannabinoid system in drug addiction.
Maldonado R; Valverde O; Berrendero F
Trends Neurosci; 2006 Apr; 29(4):225-32. PubMed ID: 16483675
[TBL] [Abstract][Full Text] [Related]
22. Circuitry for associative plasticity in the amygdala involves endocannabinoid signaling.
Azad SC; Monory K; Marsicano G; Cravatt BF; Lutz B; Zieglgänsberger W; Rammes G
J Neurosci; 2004 Nov; 24(44):9953-61. PubMed ID: 15525780
[TBL] [Abstract][Full Text] [Related]
23. Endocannabinoid signaling and synaptic plasticity in the brain.
Zhu PJ
Crit Rev Neurobiol; 2006; 18(1-2):113-24. PubMed ID: 17725514
[TBL] [Abstract][Full Text] [Related]
24. Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area.
Mátyás F; Urbán GM; Watanabe M; Mackie K; Zimmer A; Freund TF; Katona I
Neuropharmacology; 2008 Jan; 54(1):95-107. PubMed ID: 17655884
[TBL] [Abstract][Full Text] [Related]
25. Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models.
Kreitzer AC; Malenka RC
Nature; 2007 Feb; 445(7128):643-7. PubMed ID: 17287809
[TBL] [Abstract][Full Text] [Related]
26. Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons.
Melis M; Perra S; Muntoni AL; Pillolla G; Lutz B; Marsicano G; Di Marzo V; Gessa GL; Pistis M
J Neurosci; 2004 Nov; 24(47):10707-15. PubMed ID: 15564588
[TBL] [Abstract][Full Text] [Related]
27. Input-specific plasticity at excitatory synapses mediated by endocannabinoids in the dentate gyrus.
Chiu CQ; Castillo PE
Neuropharmacology; 2008 Jan; 54(1):68-78. PubMed ID: 17706254
[TBL] [Abstract][Full Text] [Related]
28. Differential regulation of synaptic inputs by constitutively released endocannabinoids and exogenous cannabinoids.
Hentges ST; Low MJ; Williams JT
J Neurosci; 2005 Oct; 25(42):9746-51. PubMed ID: 16237178
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of the CB1 cannabinoid receptor and related molecular elements of the endocannabinoid system in epileptic human hippocampus.
Ludányi A; Eross L; Czirják S; Vajda J; Halász P; Watanabe M; Palkovits M; Maglóczky Z; Freund TF; Katona I
J Neurosci; 2008 Mar; 28(12):2976-90. PubMed ID: 18354002
[TBL] [Abstract][Full Text] [Related]
30. Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses.
Kim J; Alger BE
Nat Neurosci; 2010 May; 13(5):592-600. PubMed ID: 20348918
[TBL] [Abstract][Full Text] [Related]
31. Endocannabinoid-mediated metaplasticity in the hippocampus.
Chevaleyre V; Castillo PE
Neuron; 2004 Sep; 43(6):871-81. PubMed ID: 15363397
[TBL] [Abstract][Full Text] [Related]
32. The role of the CB1 cannabinoid receptor and its endogenous ligands, anandamide and 2-arachidonoylglycerol, in amphetamine-induced behavioural sensitization.
Thiemann G; van der Stelt M; Petrosino S; Molleman A; Di Marzo V; Hasenöhrl RU
Behav Brain Res; 2008 Mar; 187(2):289-96. PubMed ID: 17988751
[TBL] [Abstract][Full Text] [Related]
33. Endocannabinoid liberation from neurons in transsynaptic signaling.
Lovinger DM
J Mol Neurosci; 2007 Sep; 33(1):87-93. PubMed ID: 17901551
[TBL] [Abstract][Full Text] [Related]
34. Hardwiring the brain: endocannabinoids shape neuronal connectivity.
Berghuis P; Rajnicek AM; Morozov YM; Ross RA; Mulder J; Urbán GM; Monory K; Marsicano G; Matteoli M; Canty A; Irving AJ; Katona I; Yanagawa Y; Rakic P; Lutz B; Mackie K; Harkany T
Science; 2007 May; 316(5828):1212-6. PubMed ID: 17525344
[TBL] [Abstract][Full Text] [Related]
35. Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding.
Izzo AA; Piscitelli F; Capasso R; Aviello G; Romano B; Borrelli F; Petrosino S; Di Marzo V
Br J Pharmacol; 2009 Sep; 158(2):451-61. PubMed ID: 19371345
[TBL] [Abstract][Full Text] [Related]
36. Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia.
Nyilas R; Gregg LC; Mackie K; Watanabe M; Zimmer A; Hohmann AG; Katona I
Eur J Neurosci; 2009 May; 29(10):1964-78. PubMed ID: 19453631
[TBL] [Abstract][Full Text] [Related]
37. Endocannabinoid- and mGluR5-dependent short-term synaptic depression in an isolated neuron/bouton preparation from the hippocampal CA1 region.
Sheinin A; Talani G; Davis MI; Lovinger DM
J Neurophysiol; 2008 Aug; 100(2):1041-52. PubMed ID: 18497350
[TBL] [Abstract][Full Text] [Related]
38. Dietary PUFAs and Exercise Dynamic Actions on Endocannabinoids in Brain: Consequences for Neural Plasticity and Neuroinflammation.
Park Y; Watkins BA
Adv Nutr; 2022 Oct; 13(5):1989-2001. PubMed ID: 35675221
[TBL] [Abstract][Full Text] [Related]
39. Electroconvulsive shock treatment differentially modulates cortical and subcortical endocannabinoid activity.
Hill MN; Barr AM; Ho WS; Carrier EJ; Gorzalka BB; Hillard CJ
J Neurochem; 2007 Oct; 103(1):47-56. PubMed ID: 17561935
[TBL] [Abstract][Full Text] [Related]
40. Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver.
Jeong WI; Osei-Hyiaman D; Park O; Liu J; Bátkai S; Mukhopadhyay P; Horiguchi N; Harvey-White J; Marsicano G; Lutz B; Gao B; Kunos G
Cell Metab; 2008 Mar; 7(3):227-35. PubMed ID: 18316028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
